Vaxart Inc. [NASDAQ: VXRT] traded at a low on 08/12/20, posting a -14.42 loss after which it closed the day’ session at $9.20. The company report on August 12, 2020 that Lost Money in Vaxart, Inc.?.
Gibbs Law Group Investigates Potential Securities Law Violations.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Vaxart, Inc. shares fell significantly after reports that the company may have misled investors regarding its inclusion in Operation Warp Speed, the U.S. government program aimed at developing and delivering COVID-19 vaccines and therapies. Gibbs Law Group is investigating a potential Vaxart Class Action Lawsuit on behalf of investors who lost money in Vaxart, Inc. (NASDAQ: VXRT) stock.
The results of the trading session contributed to over 24194399 shares changing hands. Over the past one week, the price volatility of Vaxart Inc. stands at 17.96% while the volatility over the past one month is 14.84%.
The market cap for VXRT stock reached $977.41 million, with 109.09 million shares outstanding and 108.40 million shares in the current float. Compared to the average trading volume of 25.59M shares, VXRT reached a trading volume of 24194399 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Vaxart Inc. [VXRT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VXRT shares is $11.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VXRT stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Vaxart Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 12, 2020. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on July 13, 2020, representing the official price target for Vaxart Inc. stock.
The Average True Range (ATR) for Vaxart Inc. is set at 1.83, with the Price to Sales ratio for VXRT stock in the period of the last 12 months amounting to 132.08. The Price to Book ratio for the last quarter was 21.96, with the Price to Cash per share for the same quarter was set at 0.42.
How has VXRT stock performed recently?
Vaxart Inc. [VXRT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.81. With this latest performance, VXRT shares dropped by -45.79% in over the last four-week period, additionally plugging by 767.92% over the last 6 months – not to mention a rise of 1275.19% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VXRT stock in for the last two-week period is set at 47.93, with the RSI for the last a single of trading hit 42.43, and the three-weeks RSI is set at 49.97 for Vaxart Inc. [VXRT]. The present Moving Average for the last 50 days of trading for this stock 7.99, while it was recorded at 9.53 for the last single week of trading, and 3.01 for the last 200 days.
Vaxart Inc. [VXRT]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Vaxart Inc. [VXRT] shares currently have an operating margin of -110.17. Vaxart Inc.’s Net Margin is presently recorded at -189.06.
Return on Total Capital for VXRT is now -33.85, given the latest momentum, and Return on Invested Capital for the company is -67.27. Return on Equity for this stock declined to -154.15, with Return on Assets sitting at -51.61. When it comes to the capital structure of this company, Vaxart Inc. [VXRT] has a Total Debt to Total Equity ratio set at 143.95. Additionally, VXRT Total Debt to Total Capital is recorded at 59.01, with Total Debt to Total Assets ending up at 50.35. Long-Term Debt to Equity for the company is recorded at 114.95, with the Long-Term Debt to Total Capital now at 47.12.
Reflecting on the efficiency of the workforce at the company, Vaxart Inc. [VXRT] managed to generate an average of -$1,331,786 per employee. Receivables Turnover for the company is 3.64 with a Total Asset Turnover recorded at a value of 0.27.Vaxart Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.00 and a Current Ratio set at 4.00.
Earnings analysis for Vaxart Inc. [VXRT]
With the latest financial reports released by the company, Vaxart Inc. posted -0.32/share EPS, while the average EPS was predicted by analysts to be reported at -0.35/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 8.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VXRT.
Insider trade positions for Vaxart Inc. [VXRT]
There are presently around $291 million, or 9.40% of VXRT stock, in the hands of institutional investors. The top three institutional holders of VXRT stocks are: ARMISTICE CAPITAL, LLC with ownership of 25,200,000, which is approximately 0% of the company’s market cap and around 0.10% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 2,173,728 shares of the stock with an approximate value of $20.0 million in VXRT stocks shares; and VANGUARD GROUP INC, currently with $5.93 million in VXRT stock with ownership of nearly 1840.103% of the company’s market capitalization.
53 institutional holders increased their position in Vaxart Inc. [NASDAQ:VXRT] by around 4,432,846 shares. Additionally, 8 investors decreased positions by around 443,094 shares, while 8 investors held positions by with 26,736,768 shares. The mentioned changes placed institutional holdings at 31,612,708 shares, according to the latest SEC report filing. VXRT stock had 41 new institutional investments in for a total of 1,817,033 shares, while 5 institutional investors sold positions of 100,154 shares during the same period.